Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y. Agid

Showing results (81-90 of 611) with videos related to

Pageof 62
Sort By:
Journal of Neurochemistry|October 1, 1987
Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's diseaseR Cash, R Raisman, A Ploska, et al.
European Journal of Pharmacology|October 29, 1985
High and low affinity [3H]imipramine binding sites in control and parkinsonian brainsR Cash, R Raisman, A Ploska, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1981
Bromocriptine in Parkinson's disease: a study of cardiovascular effectsN Quinn, A Illas, F Lhermitte, et al.
Neurology|June 1, 1981
Bromocriptine and domperidone in the treatment of Parkinson diseaseN Quinn, A Illas, F Lhermitte, et al.
La Revue De Medecine Interne|September 10, 1999
[Genetics of Parkinson disease]D Brassat, A Durr, Y Agid, et al.
Neurology|February 1, 1994
Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunctionC Malapani, B Pillon, B Dubois, et al.
Revue Neurologique|January 1, 1984
[Meningo-myelitis with a favorable course after measles vaccination]M Serdaru, L Lacomblez, F Danzé, et al.
Brain Research|May 6, 1977
Retrograde axonal transport of 125I-tetanus toxin as a tool for tracing fiber connections in the central nervous system; connections of the rostral part of the rat neostriatumM Schwab, Y Agid, J Glowinski, et al.
Archives of Neurology|April 1, 1993
Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseasesB Pillon, B Deweer, Y Agid, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Selective vulnerability of pigmented dopaminergic neurons in Parkinson's diseaseE C Hirsch, A M Graybiel, Y Agid
Pageof 62

Showing results (81-90 of 611) with videos related to

Sort By:
Pageof 62
Journal of Neurochemistry|October 1, 1987
Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's diseaseR Cash, R Raisman, A Ploska, et al.
European Journal of Pharmacology|October 29, 1985
High and low affinity [3H]imipramine binding sites in control and parkinsonian brainsR Cash, R Raisman, A Ploska, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1981
Bromocriptine in Parkinson's disease: a study of cardiovascular effectsN Quinn, A Illas, F Lhermitte, et al.
Neurology|June 1, 1981
Bromocriptine and domperidone in the treatment of Parkinson diseaseN Quinn, A Illas, F Lhermitte, et al.
La Revue De Medecine Interne|September 10, 1999
[Genetics of Parkinson disease]D Brassat, A Durr, Y Agid, et al.
Neurology|February 1, 1994
Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunctionC Malapani, B Pillon, B Dubois, et al.
Revue Neurologique|January 1, 1984
[Meningo-myelitis with a favorable course after measles vaccination]M Serdaru, L Lacomblez, F Danzé, et al.
Brain Research|May 6, 1977
Retrograde axonal transport of 125I-tetanus toxin as a tool for tracing fiber connections in the central nervous system; connections of the rostral part of the rat neostriatumM Schwab, Y Agid, J Glowinski, et al.
Archives of Neurology|April 1, 1993
Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseasesB Pillon, B Deweer, Y Agid, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1989
Selective vulnerability of pigmented dopaminergic neurons in Parkinson's diseaseE C Hirsch, A M Graybiel, Y Agid
Pageof 62